Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.

Frontiers in immunology - 1 Jan 2021

Jin Yi, Wang Zhanwang, He Dong, Zhu Yuxing, Hu Xueying, Gong Lian, Xiao Mengqing, Chen Xingyu, Cheng Yaxin, Cao Ke

Abstract excerpt

Adrenocortical carcinoma (ACC) is a rare endocrine malignancy with a high rate of mortality and recurrence. N6-methyladenosine methylation (m6A) is the most common modification to affect cancer development, but to date, the potential role of m6A regulators in ACC prognosis is not well understood. In this study, we systematically analyzed 21 m6A regulators in ACC samples from The Cancer Genome Atlas (TCGA) and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenosine
Share to Adrenal Cortex Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Adrenocortical Carcinoma

Share to Databases, Genetic

Share to Heterogeneous-Nuclear Ribonucleoprotein Group A-B

Share to MicroRNAs

Share to RNA, Long Noncoding

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 33746977
DOI: 10.3389/fimmu.2021.637933
PMCID: PMC7966528

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma.PMID 33746977Read ↗

Elucidating the clinical and immunological value of m6A regulator-mediated methylation modification patterns in adrenocortical carcinomaSemantic proximity Read ↗

Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinomaSemantic proximity Read ↗

A four-m6A methylation regulator risk score was an independent prognostic biomarker for adrenocortical carcinomaSemantic proximity Read ↗

Analysis of m7G-Related Signatures in Adrenocortical Carcinoma and Their Correlation with SurvivalSemantic proximity Read ↗

The Characteristics of Tumor Microenvironment Predict Survival and Response to Immunotherapy in Adrenocortical CarcinomasSemantic proximity Read ↗

Comprehensive Characterization of m6A Regulators-Mediated Methylation Modification Patterns and Tumor Microenvironment Signature in Breast CancerSemantic proximity Read ↗

Construction of a m6A RNA Methylation Regulator-related Signature for Prognosis and Immune Response in Lung AdenocarcinomaSemantic proximity Read ↗

Molecular characterization and prognostic relevance of m6A regulators in pancreatic adenocarcinomaSemantic proximity Read ↗

m6A RNA Methylation Regulators de fine tumor microenvironment and predict prognosis in hepatocellular carcinomaSemantic proximity Read ↗

Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methodsSemantic proximity Read ↗

RNA m6A methylation regulator-mediated modification patterns and tumor microenvironment characterization in hepatocellular carcinomaSemantic proximity Read ↗

A Signature of N6-methyladenosine Regulator-Related Genes Predicts Prognoses and Immune Responses for Head and Neck Squamous Cell CarcinomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.